Illumina teams up with Pillar Biosciences to enhance cancer treatment options
The primary objective of the collaboration is to make Pillar's suite of oncology assays available worldwide, adding a…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 Jul 23
The primary objective of the collaboration is to make Pillar's suite of oncology assays available worldwide, adding a…
26 Jul 23
The FDA’s approval was based on the findings of Saturn-1 and Saturn-2 trials in which XDEMVY showed considerable…
26 Jul 23
Collaboration Builds upon Fujirebio Expertise in Neurodegenerative Disease Assays and Beckman Coulter's High Sensitivity, High Throughput, Global Installed…
26 Jul 23
Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today…
26 Jul 23
The institute has awarded Chicago Medical School investigator Grace Stutzmann $1.8m— part of a $2.4m grant in collaboration…
26 Jul 23
Solar Biotech Canada will transform consumer goods to ensure a sustainable future
26 Jul 23
We are thrilled to announce that Alvinesa Natural Ingredients has successfully acquired Genosa. This acquisition marks a significant…
25 Jul 23
Zilebesiran is an investigational, subcutaneously administered RNAi therapeutic that targets angiotensinogen (AGT), which regulates blood pressure and fluid…
25 Jul 23
According to the conditions of the exchange offer, Johnson & Johnson’s shareholders can trade all, some, or none…
25 Jul 23
Upon conclusion of the deal, Quince will fund the EryDex through the Phase 3 clinical trial under special…